Home - Products - Apoptosis - NF-κB - Antiproliferative agent-22

Antiproliferative agent-22

CAS No. 1374305-45-9

Antiproliferative agent-22( —— )

Catalog No. M37583 CAS No. 1374305-45-9

Antiproliferative agent-22 is an anticancer compound that shows antiproliferative activity on MCF-7, MDA-MB-231, and MDA-MB-468 cells.Antiproliferative agent-22 is used in cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Antiproliferative agent-22
  • Note
    Research use only, not for human use.
  • Brief Description
    Antiproliferative agent-22 is an anticancer compound that shows antiproliferative activity on MCF-7, MDA-MB-231, and MDA-MB-468 cells.Antiproliferative agent-22 is used in cancer research.
  • Description
    Antiproliferative agent-22 (compound 2) is an anticancer agent. Antiproliferative agent-22 shoes anti-proliferative activities against MCF-7, MDA-MB-231 and MDA-MB-468 cells with IC50 values of 6.2 μM, 3.3 μM and 3.3 μM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    NF-κB
  • Recptor
    NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1374305-45-9
  • Formula Weight
    307.3
  • Molecular Formula
    C17H13N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(\NC(=O)C=1C=CN=CC1)=C\2/C=3C(C(=O)C(C)=C2)=CC=CC3O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Prasad Dandawate, et al. Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells. Bioorg Med Chem Lett. 2012 May 1;22(9):3104-8. ?
molnova catalog
related products
  • Loganin

    Loganin,an iridoid glucosides,has been reported to be an inhibitor of Cox-1 and also noted to suppress TNF-α formation.

  • CHPG sodium salt

    CHPG sodium salt is a selective agonist of mGluR5 that activates ERK and Akt signaling pathways and is utilized in studies on traumatic brain injury.

  • Iguratimod

    A novel disease-modifying antirheumatic drug that inhibits NF-kappaB (NF-κB) p65 subunit (RelA) phosphorylation and nuclear translocation without affecting IKBα degradation.